跳至主要内容
临床试验/NCT06739512
NCT06739512尚未招募不适用

Efficacy and Safety of Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation: a Multicenter Randomized Controlled Trial

Shanghai Chest Hospital1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2024年12月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
600
试验地点
1
主要终点
Freedom from Atrial Arrhythmia Recurrence at 12 Months

研究概览

简要总结

This multicenter, randomized, controlled trial aims to evaluate the efficacy and safety of pulsed field ablation (PFA) in patients with persistent atrial fibrillation (PeAF). We will compare three distinct substrate ablation strategies: anatomical guided ablation (ANAT group), electrogram guided ablation (EGM group), and extensive electro-anatomical guided ablation (EXT group). The study seeks to identify which ablation strategy yields the highest efficacy and safety profiles to potentially guide future clinical practice in the management of PeAF.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults aged 18-80 years diagnosed with persistent atrial fibrillation.
  • •Ineffectiveness or intolerance to at least one Class I or III anti-arrhythmic drug.

排除标准

  • •Major valvular diseases needing surgical intervention.
  • •Presence of a left atrial thrombus on recent imaging.
  • •Recent myocardial infarction or severe heart failure (LVEF ≤ 30%).
  • •Current Severe Infection.

研究组 & 干预措施

Anatomical Guided Ablation Group

Placebo Comparator

This group will undergo pulmonary vein isolation (PVI) combined with anatomical linear ablation based on predefined anatomical landmarks (a complete posterior wall box isolation to ensure comprehensive atrial substrate modification), including lines such as the mitral isthmus and roofline. The ablation will aim to create bidirectional block without relying on electrogram-based mapping.

干预措施: Anatomical Guided Ablation (Procedure)

Electrogram Guided Ablation Group

Active Comparator

This group will undergo PVI and targeted ablation of atrial fibrillation "drivers" identified through electrogram-guided mapping. The mapping will focus on electrograms with characteristics such as spatial-temporal dispersion, high-frequency potentials, and short local cycle lengths.

干预措施: Electrogram Guided Ablation (Procedure)

Extensive Electro-Anatomical Guided Ablation Group

Experimental

This group will receive PVI and a combination of anatomical linear ablation (a complete posterior wall box isolation to ensure comprehensive atrial substrate modification) and electrogram-guided ablation. It represents an extensive strategy that integrates both anatomical and potential-based mapping for optimized ablation targeting.

干预措施: Extensive Electro-Anatomical Guided Ablation (Procedure)

结局指标

主要结局

Freedom from Atrial Arrhythmia Recurrence at 12 Months

时间窗: 12 months after ablation procedure

Proportion of participants free from atrial fibrillation/atrial flutter/atrial tachycardia recurrence at 12 months post-ablation.

次要结局

  • Procedural Safety(From enrollment to completion of follow-up(at least 12 months))
  • Symptom Relief and Quality of Life Enhancement.(From enrollment to completion of follow-up(at least 12 months))
  • Atrial Fibrillation Burden Reduction(From enrollment to completion of follow-up(at least 12 months))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xu Liu

MD

Shanghai Chest Hospital

研究点 (1)

Loading locations...

相似试验